Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer

Figure 2

Immunostaining of nuclear factor (erythroid-2)–related factor 2 (Nrf2) in clinical gastric cancer samples. Representative immunostaining of Nrf2 in (a) Positive control, noncancerous placental tissue; (b) normal stomach tissue; (c – e) Gastric cancer tissues; (c) negative staining of Nrf2, (d) weak staining (+1) of Nrf2, (e) strong staining (+2) of Nrf2 (original magnification, ×400). Expression of Nrf2 in clinical samples. Immunostaining of Nrf2 (original magnification, ×400)

Back to article page